Skip to main content

Advertisement

SpringerLink
Log in

Trends in the global immuno-oncology landscape

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

An Erratum to this article was published on 26 October 2018

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Trends in the global IO pipeline.
Figure 2: Trends in IO targets.
Figure 3: Trends in organizations with IO agents in clinical development.

Change history

  • 26 October 2018

    In the original version of Figure 1, the label on the y axis 'T cell-targeted' was incorrect and should be 'T cell-targeted immunomodulator'. The article has been corrected in the online version.

Author information

Authors and Affiliations

  1. Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA

    Jun Tang, Laura Pearce, Jill O'Donnell-Tormey & Vanessa M. Hubbard-Lucey

Authors
  1. Jun Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jill O'Donnell-Tormey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vanessa M. Hubbard-Lucey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Tang.

Ethics declarations

Competing interests

J.O-T. is a paid board member of HemaCare. L. P. is a consultant to Cancer Research Institute and Canadian Cancer Trials Group.

Related links

PowerPoint slides

Supplementary information

Supplementary information

Supplementary Table (XLSX 23 kb)

Supplementary information

Trends of TAA-targeted IO agents in the past year. (PDF 183 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, J., Pearce, L., O'Donnell-Tormey, J. et al. Trends in the global immuno-oncology landscape. Nat Rev Drug Discov 17, 783–784 (2018). https://doi.org/10.1038/nrd.2018.167

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2018.167

  • Springer Nature Limited

This article is cited by

Search

Navigation